Nwam LLC Makes New $222,000 Investment in DocuSign, Inc. (NASDAQ:DOCU)

Nwam LLC acquired a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 2,467 shares of the company’s stock, valued at approximately $222,000.

A number of other institutional investors have also made changes to their positions in DOCU. Toronto Dominion Bank increased its stake in DocuSign by 30.3% during the 3rd quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock worth $1,624,000 after buying an additional 6,081 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of DocuSign by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock valued at $82,478,000 after acquiring an additional 16,014 shares in the last quarter. Quantinno Capital Management LP lifted its stake in shares of DocuSign by 39.5% in the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock worth $12,514,000 after acquiring an additional 57,104 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in shares of DocuSign by 7.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after acquiring an additional 85,987 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in DocuSign by 118.8% in the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock valued at $54,695,000 after purchasing an additional 330,136 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the completion of the sale, the director now directly owns 7,736 shares of the company’s stock, valued at approximately $731,825.60. This represents a 6.46 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Daniel D. Springer sold 581,588 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the sale, the director now owns 906,430 shares of the company’s stock, valued at $87,959,967.20. This trade represents a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 693,773 shares of company stock valued at $66,727,926. Insiders own 1.66% of the company’s stock.

DocuSign Stock Up 2.3 %

Shares of DOCU stock opened at $83.17 on Friday. The company has a market cap of $16.80 billion, a P/E ratio of 17.15, a PEG ratio of 6.94 and a beta of 0.89. The business has a 50 day moving average of $90.43 and a two-hundred day moving average of $77.74. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Robert W. Baird upped their target price on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Citigroup upped their price target on shares of DocuSign from $87.00 to $113.00 and gave the company a “buy” rating in a report on Friday, December 6th. HSBC reiterated a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Morgan Stanley boosted their target price on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Friday, December 6th. Finally, Hsbc Global Res raised shares of DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, DocuSign currently has a consensus rating of “Hold” and a consensus price target of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.